PREVIOUS
✖
Essential Medicines 2025
September 10 , 2025
10 hrs 0 min
21
0
- The World Health Organization (WHO) released the 24th edition of the Model List of Essential Medicines (EML) and the 10th edition for children (EMLc).
- Twenty new medicines were added to the adult list and fifteen to the children’s list, reflecting urgent public health needs.
- Cancer is the second leading cause of death globally, causing nearly 10 million deaths each year.
- Only cancer medicines proven to prolong life by at least 4 to 6 months were added after strict evaluation.
- Pembrolizumab, an immune checkpoint inhibitor, was added for metastatic cervical, colorectal, and non-small cell lung cancers.
- Atezolizumab and cemiplimab were included as alternative immunotherapy options for lung cancer.
- Diabetes affects over 800 million people worldwide, with many untreated, while more than one billion suffer from obesity.
- Glucagon-like peptide-1 (GLP-1) receptor agonists semaglutide, dulaglutide, and liraglutide were added for type 2 diabetes with cardiovascular or kidney disease and obesity.
- The dual receptor agonist tirzepatide, targeting GLP-1 and glucose-dependent insulinotropic polypeptide (GIP), was also added.
- These medicines help improve blood sugar control, reduce heart and kidney complications, and support weight loss.
- The Model Lists are updated biennially to promote affordable access to priority medicines in over 150 countries worldwide.
Leave a Reply
Your Comment is awaiting moderation.